WVU Names Goldberg New Director

Richard M. Goldberg, MD, an expert in gastrointestinal cancer, has been named the new director of the WVU Cancer Institute. Dr. Goldberg joined WVU from Ohio State University’s Wexner Medical Center, where he served as the Klotz Family Professor of Cancer Research, the physician‐in‐chief of the James Cancer Hospital, and the associate director of the Ohio State Comprehensive Cancer Center.

Prior to arriving at Ohio State, Dr. Goldberg served as the physician‐in‐chief and division chief for Hematology and Oncology at the University of North Carolina, where he was also the Richard M. Goldberg Professor of GI Cancer Research and associate director for clinical research of the Lineberger Comprehensive Cancer Center.

Dr. Goldberg is the co‐chair of the Society for Translational Oncology, participates in the CEO Roundtable on Cancer, and serves or has served on numerous editorial boards. He was the first president of the International Society of Gastrointestinal Oncology. He has held multiple National Cancer Institute-funded grants, and his research has resulted in more than 300 peer-reviewed publications. He is also the associate group chair for the Alliance for Clinical Trials in Oncology, serving on the board of directors, board of trustees, and the Alliance Foundation board of trustees.

Dr. Goldberg is a fellow of both the American College of Physicians and the American Society of Clinical Oncology. He has lectured worldwide on GI cancer topics and is well known as a mentor for junior colleagues who now serve in responsible academic leadership roles themselves. He has been consistently honored by Best Doctors.